AngioScore in Japan
This article was originally published in The Gray Sheet
Executive Summary
Firm plans an April launch of its AngioSculpt scoring balloon catheter in Japan for treatment of coronary artery disease, AngioScore announces upon approval in that country Jan. 28. Available in Europe since 2004, AngioSculpt received FDA approval in January 2007 for use in the coronary arteries (1"The Gray Sheet" Jan. 15, 2007, p. 16). According to AngioScore, more than 180,000 interventional procedures are done in Japan each year
You may also be interested in...
AngioSculpt Scoring Balloon Catheter Gets PMA For Coronary Artery Disease
AngioScore may become an acquisition target for a larger interventional cardiology company following the Jan. 8 FDA approval of its AngioSculpt scoring balloon catheter to treat coronary artery stenosis
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.